Venlafaxine Hydrochloride Capsule, Extended Release
Product Images NDC 50090-6834

5 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 50090-6834). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-01 (Image 01)

Image-01 (Image 01)
Chemical structure of venlafaxine hydrochloride showing its molecular arrangement, including a cyclohexanol ring, a dimethylamino group, and a methoxyphenyl group, labeled with the compound name at the bottom.*
FDA Label Image

Image-02 (Image 02)

Image-02 (Image 02)
A dot plot chart depicting fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of venlafaxine and its metabolite ODV across special populations, including hepatic impairment (cirrhosis, mild, moderate), renal impairment (mild/moderate, hemodialysis), CYP2D6 polymorphism metabolizer status, age over 60 years, and gender. The x-axis shows change relative to the reference value, ranging from 0 to 3.5.*
FDA Label Image

Image-03 (Image 03)

Image-03 (Image 03)
A scatter plot chart showing fold change and 90% confidence intervals for pharmacokinetic parameters (Cmax and AUC) of venlafaxine and its metabolite ODV when interacted with various drugs, including Ethanol, Diazepam, Cimetidine, Ketoconazole, Indinavir, Metoprolol, Imipramine, and Lithium. The x-axis represents the change relative to the reference value, ranging from 0 to 3.*
FDA Label Image

Image-04 (Image 04)

Image-04 (Image 04)
A chart showing the fold change and 90% confidence intervals in pharmacokinetic parameters (Cmax, AUC) for various interacting drugs and their analytes compared to a reference value. The x-axis represents change relative to the reference value, and data points for drugs like ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, toltubamide, and lithium are plotted with error bars.*
FDA Label Image

Label Image (Lbl500906834)

Label Image (Lbl500906834)
Venlafaxine Hydrochloride 37.5 mg extended-release capsules label from A-S Medication Solutions. The label includes storage instructions, package size of 30 capsules, and mentions the contents as Venlafaxaxine Hydrochloride USP equivalent to Venlafaxine HCl. It specifies the oral route and references a dosage package insert.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.